NDA/BLA filedconf 0.95

omecamtiv mecarbil — NDA/BLA filed

$CYTK · CYTOKINETICS INC · heart failure with reduced ejection fraction (HFrEF)

Event date

Date TBD

Sponsor runway

3 mo

$129.8M liquid

Evidence

“The FDA has accepted for filing the NDA for omecamtiv mecarbil based on the results from GALACTIC-HF and has assigned a Prescription Drug User Fee Act (PDUFA) date of November 30, 2022.”

Source: 8-K filed 2022-04-04View on EDGAR ↗0001171843-22-002319

Comparable historical nda/bla fileds· last 5 years · same indication

Ticker	Drug	Date	Outcome
$CYTK	omecamtiv mecarbil	2022-02-04	unknown

Recent insider activity· ±90 days

11 insiders · 0 buys · 29 sells

Exercise10b5-1

2026-05-19

Malik Fady Ibraham

EVP Research & Development

3,500 @ $7.80$27K

Sell10b5-1

2026-05-19

Malik Fady Ibraham

EVP Research & Development

3,500 @ $75.69$265K

Sell10b5-1

2026-05-14

Blum Robert I

President & CEO

7,500 @ $77.92$584K

Sell10b5-1

2026-05-05

Callos Andrew

EVP, Chief Commercial Officer

11,333 @ $77.25$875K

Exercise10b5-1

2026-05-05

Callos Andrew

EVP, Chief Commercial Officer

11,333 @ $39.13$443K

Sell10b5-1

2026-05-05

HENDERSON JOHN T

Director

20,000 @ $75.97$1.52M

Exercise10b5-1

2026-05-05

WIERENGA WENDELL

Director

4,032 @ $12.40$50K

Sell10b5-1

2026-05-05

WIERENGA WENDELL

Director

4,032 @ $75.00$302K

Exercise10b5-1

2026-05-05

Malik Fady Ibraham

EVP Research & Development

3,500 @ $7.80$27K

Sell10b5-1

2026-05-05

Lee Sung

EVP, Chief Financial Officer

23,906 @ $76.87$1.84M

Sell10b5-1

2026-05-05

Malik Fady Ibraham

EVP Research & Development

3,500 @ $77.37$271K

Exercise10b5-1

2026-05-05

HENDERSON JOHN T

Director

20,000 @ $7.61$152K

Exercise10b5-1

2026-05-01

Callos Andrew

EVP, Chief Commercial Officer

15,857 @ $37.63$597K

Sell10b5-1

2026-05-01

Callos Andrew

EVP, Chief Commercial Officer

15,857 @ $65.00$1.03M

Sell10b5-1

2026-04-30

Callos Andrew

EVP, Chief Commercial Officer

15,000 @ $63.26$949K

Exercise10b5-1

2026-04-30

Callos Andrew

EVP, Chief Commercial Officer

15,000 @ $23.26$349K

Sell10b5-1

2026-04-29

Blum Robert I

President & CEO

7,500 @ $59.62$447K

Exercise10b5-1

2026-04-21

Malik Fady Ibraham

EVP Research & Development

3,500 @ $7.80$27K

Sell10b5-1

2026-04-21

Malik Fady Ibraham

EVP Research & Development

3,500 @ $65.69$230K

Sell10b5-1

2026-04-15

Blum Robert I

President & CEO

7,500 @ $65.38$490K

Sell10b5-1

2026-04-15

Callos Andrew

EVP, Chief Commercial Officer

7,449 @ $66.02$492K

Grant

2026-04-15

Daly James M

Director

191 @ $65.37$12K

Grant

2026-04-15

Wysenski Nancy

Director

95 @ $65.37$6K

Grant

2026-04-15

HENDERSON JOHN T

Director

325 @ $65.37$21K

Grant

2026-04-15

WIERENGA WENDELL

Director

95 @ $65.37$6K

Grant

2026-04-15

Kaye Edward M. MD

Director

191 @ $65.37$12K

Grant

2026-04-15

Harrington Robert Arthur

Director

191 @ $65.37$12K

Sell10b5-1

2026-04-07

Malik Fady Ibraham

EVP Research & Development

1,000 @ $64.75$65K

Exercise10b5-1

2026-04-07

Malik Fady Ibraham

EVP Research & Development

1,000 @ $10.60$11K

Sell10b5-1

2026-04-07

Malik Fady Ibraham

EVP Research & Development

3,500 @ $65.21$228K

Exercise10b5-1

2026-04-07

Malik Fady Ibraham

EVP Research & Development

3,500 @ $7.80$27K

Sell10b5-1

2026-04-01

Blum Robert I

President & CEO

7,500 @ $66.63$500K

Sell10b5-1

2026-03-31

Callos Andrew

EVP, Chief Commercial Officer

3,639 @ $65.00$237K

Sell10b5-1

2026-03-18

Callos Andrew

EVP, Chief Commercial Officer

1,930 @ $62.07$120K

Sell

2026-03-17

Malik Fady Ibraham

EVP Research & Development

7,636 @ $62.15$475K

Sell

2026-03-17

Callos Andrew

EVP, Chief Commercial Officer

2,916 @ $62.15$181K

Sell

2026-03-17

Lee Sung

EVP, Chief Financial Officer

4,935 @ $62.15$307K

Sell

2026-03-17

Blum Robert I

President & CEO

23,928 @ $62.15$1.49M

Sell

2026-03-17

Blum Robert I

President & CEO

12,673 @ $62.15$788K

Sell

2026-03-17

Callos Andrew

EVP, Chief Commercial Officer

5,626 @ $62.15$350K

Sell

2026-03-17

Malik Fady Ibraham

EVP Research & Development

4,397 @ $62.15$273K

Sell10b5-1

2026-03-16

Callos Andrew

EVP, Chief Commercial Officer

1,709 @ $61.03$104K

Grant

2026-03-15

Lee Sung

EVP, Chief Financial Officer

29,480 @ ——

Grant

2026-03-15

Malik Fady Ibraham

EVP Research & Development

27,306 @ ——

Grant

2026-03-15

Malik Fady Ibraham

EVP Research & Development

1,665 @ ——

Grant

2026-03-15

Malik Fady Ibraham

EVP Research & Development

39,527 @ ——

Grant

2026-03-15

Blum Robert I

President & CEO

75,258 @ ——

Grant

2026-03-15

Blum Robert I

President & CEO

1,665 @ ——

Grant

2026-03-15

Blum Robert I

President & CEO

111,864 @ ——

Grant

2026-03-15

Hessekiel Jeffrey

Chief Legal & Admin Officer

20,646 @ ——

+ 11 more

Date	Insider	Action	Shares	Price	Value
2026-05-19	Malik Fady IbrahamEVP Research & Development	Exercise10b5-1	3,500	$7.80	$27K
2026-05-19	Malik Fady IbrahamEVP Research & Development	Sell10b5-1	3,500	$75.69	$265K
2026-05-14	Blum Robert IPresident & CEO	Sell10b5-1	7,500	$77.92	$584K
2026-05-05	Callos AndrewEVP, Chief Commercial Officer	Sell10b5-1	11,333	$77.25	$875K
2026-05-05	Callos AndrewEVP, Chief Commercial Officer	Exercise10b5-1	11,333	$39.13	$443K
2026-05-05	HENDERSON JOHN TDirector	Sell10b5-1	20,000	$75.97	$1.52M
2026-05-05	WIERENGA WENDELLDirector	Exercise10b5-1	4,032	$12.40	$50K
2026-05-05	WIERENGA WENDELLDirector	Sell10b5-1	4,032	$75.00	$302K
2026-05-05	Malik Fady IbrahamEVP Research & Development	Exercise10b5-1	3,500	$7.80	$27K
2026-05-05	Lee SungEVP, Chief Financial Officer	Sell10b5-1	23,906	$76.87	$1.84M
2026-05-05	Malik Fady IbrahamEVP Research & Development	Sell10b5-1	3,500	$77.37	$271K
2026-05-05	HENDERSON JOHN TDirector	Exercise10b5-1	20,000	$7.61	$152K
2026-05-01	Callos AndrewEVP, Chief Commercial Officer	Exercise10b5-1	15,857	$37.63	$597K
2026-05-01	Callos AndrewEVP, Chief Commercial Officer	Sell10b5-1	15,857	$65.00	$1.03M
2026-04-30	Callos AndrewEVP, Chief Commercial Officer	Sell10b5-1	15,000	$63.26	$949K
2026-04-30	Callos AndrewEVP, Chief Commercial Officer	Exercise10b5-1	15,000	$23.26	$349K
2026-04-29	Blum Robert IPresident & CEO	Sell10b5-1	7,500	$59.62	$447K
2026-04-21	Malik Fady IbrahamEVP Research & Development	Exercise10b5-1	3,500	$7.80	$27K
2026-04-21	Malik Fady IbrahamEVP Research & Development	Sell10b5-1	3,500	$65.69	$230K
2026-04-15	Blum Robert IPresident & CEO	Sell10b5-1	7,500	$65.38	$490K
2026-04-15	Callos AndrewEVP, Chief Commercial Officer	Sell10b5-1	7,449	$66.02	$492K
2026-04-15	Daly James MDirector	Grant	191	$65.37	$12K
2026-04-15	Wysenski NancyDirector	Grant	95	$65.37	$6K
2026-04-15	HENDERSON JOHN TDirector	Grant	325	$65.37	$21K
2026-04-15	WIERENGA WENDELLDirector	Grant	95	$65.37	$6K
2026-04-15	Kaye Edward M. MDDirector	Grant	191	$65.37	$12K
2026-04-15	Harrington Robert ArthurDirector	Grant	191	$65.37	$12K
2026-04-07	Malik Fady IbrahamEVP Research & Development	Sell10b5-1	1,000	$64.75	$65K
2026-04-07	Malik Fady IbrahamEVP Research & Development	Exercise10b5-1	1,000	$10.60	$11K
2026-04-07	Malik Fady IbrahamEVP Research & Development	Sell10b5-1	3,500	$65.21	$228K
2026-04-07	Malik Fady IbrahamEVP Research & Development	Exercise10b5-1	3,500	$7.80	$27K
2026-04-01	Blum Robert IPresident & CEO	Sell10b5-1	7,500	$66.63	$500K
2026-03-31	Callos AndrewEVP, Chief Commercial Officer	Sell10b5-1	3,639	$65.00	$237K
2026-03-18	Callos AndrewEVP, Chief Commercial Officer	Sell10b5-1	1,930	$62.07	$120K
2026-03-17	Malik Fady IbrahamEVP Research & Development	Sell	7,636	$62.15	$475K
2026-03-17	Callos AndrewEVP, Chief Commercial Officer	Sell	2,916	$62.15	$181K
2026-03-17	Lee SungEVP, Chief Financial Officer	Sell	4,935	$62.15	$307K
2026-03-17	Blum Robert IPresident & CEO	Sell	23,928	$62.15	$1.49M
2026-03-17	Blum Robert IPresident & CEO	Sell	12,673	$62.15	$788K
2026-03-17	Callos AndrewEVP, Chief Commercial Officer	Sell	5,626	$62.15	$350K
2026-03-17	Malik Fady IbrahamEVP Research & Development	Sell	4,397	$62.15	$273K
2026-03-16	Callos AndrewEVP, Chief Commercial Officer	Sell10b5-1	1,709	$61.03	$104K
2026-03-15	Lee SungEVP, Chief Financial Officer	Grant	29,480	—	—
2026-03-15	Malik Fady IbrahamEVP Research & Development	Grant	27,306	—	—
2026-03-15	Malik Fady IbrahamEVP Research & Development	Grant	1,665	—	—
2026-03-15	Malik Fady IbrahamEVP Research & Development	Grant	39,527	—	—
2026-03-15	Blum Robert IPresident & CEO	Grant	75,258	—	—
2026-03-15	Blum Robert IPresident & CEO	Grant	1,665	—	—
2026-03-15	Blum Robert IPresident & CEO	Grant	111,864	—	—
2026-03-15	Hessekiel JeffreyChief Legal & Admin Officer	Grant	20,646	—	—

+ 11 more transactions

← All catalysts for $CYTK